DEF 14A

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

January 29, 2025

Period of Report

January 28, 2025

Accession Number

0001628280-25-002848

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →